FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263363460> ?p ?o ?g. }

• W2263363460 endingPage "455" @default.
• W2263363460 startingPage "455" @default.
• W2263363460 abstract "Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis Weiwei Tang,1 Congwei Huang,2 Chongyin Tang,1 Jin Xu,1 Hanjin Wang11Department of General Surgery, 2Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of ChinaBackground: Galectin-3 is a member of the beta-galactoside-binding protein family and functions as a modulator of cell growth through galactoside-binding protein correlated with the occurrence and metastasis of papillary thyroid carcinoma (PTC).Methods: A systematic review of published articles on Web of Science and PubMed was performed. After establishing inclusion and exclusion criteria, nine articles were selected. Three studies referred to galectin-3 expression in PTC and non-PTC patients. Three studies referred to galectin-3 expression in PTC patients with lymph node metastasis (LNM) and without LNM. Three studies referred to galectin-3 expression in both PTC (with and without LNM) and non-PTC patients. Data analysis was performed by using RevMan5.2 software.Results: A total of 424 patients from six eligible studies that provided data about galectin-3 expression in PTC and non-PTC patients were included. A total of 378 patients from six eligible studies that provided data about galectin-3 expression in PTC with LNM and without LNM were included. Immunohistochemistry technique was used in all the studies. Galectin-3 was found to be a highly sensitive (275/424, 64.86%) marker in the diagnosis of PTC, but was found to be expressed only in a few cases involving other types of thyroid lesions (58/424, 13.68%). The odds ratio, expressed as PTC group versus other thyroid lesions group, was 13.97 (95% CI: 7.51–26.01, P<0.00001). The results also showed that the positive expression rates of galectin-3 in PTC patients with LNM were higher than those in PTC patients without LNM.Conclusion: This meta-analysis demonstrated that galectin-3 may become a potentially useful immunomarker to distinguish between PTC and non-PTC patients. In addition, PTC patients with positive expression of galectin-3 were more prone to LNM.Keywords: immunomarker, metastasis, thyroid lesions, immunohistochemistry" @default.
• W2263363460 created "2016-06-24" @default.
• W2263363460 creator A5031335804 @default.
• W2263363460 creator A5047366894 @default.
• W2263363460 creator A5063078246 @default.
• W2263363460 creator A5071814877 @default.
• W2263363460 creator A5091358989 @default.
• W2263363460 date "2016-01-01" @default.
• W2263363460 modified "2023-10-16" @default.
• W2263363460 title "Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis" @default.
• W2263363460 cites W1527544276 @default.
• W2263363460 cites W159091927 @default.
• W2263363460 cites W184454327 @default.
• W2263363460 cites W1968460133 @default.
• W2263363460 cites W1976583849 @default.
• W2263363460 cites W1982393603 @default.
• W2263363460 cites W1991965424 @default.
• W2263363460 cites W1996364285 @default.
• W2263363460 cites W2001413622 @default.
• W2263363460 cites W2003088859 @default.
• W2263363460 cites W2003128088 @default.
• W2263363460 cites W2014938343 @default.
• W2263363460 cites W2032699236 @default.
• W2263363460 cites W2047983905 @default.
• W2263363460 cites W2056616589 @default.
• W2263363460 cites W2081894326 @default.
• W2263363460 cites W2094188666 @default.
• W2263363460 cites W2140473930 @default.
• W2263363460 cites W31266416 @default.
• W2263363460 cites W782932429 @default.
• W2263363460 cites W904802307 @default.
• W2263363460 cites W2256429945 @default.
• W2263363460 cites W2412516892 @default.
• W2263363460 doi "https://doi.org/10.2147/ott.s94514" @default.
• W2263363460 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4730995" @default.
• W2263363460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26858526" @default.
• W2263363460 hasPublicationYear "2016" @default.
• W2263363460 type Work @default.
• W2263363460 sameAs 2263363460 @default.
• W2263363460 citedByCount "25" @default.
• W2263363460 countsByYear W22633634602017 @default.
• W2263363460 countsByYear W22633634602018 @default.
• W2263363460 countsByYear W22633634602019 @default.
• W2263363460 countsByYear W22633634602020 @default.
• W2263363460 countsByYear W22633634602021 @default.
• W2263363460 countsByYear W22633634602022 @default.
• W2263363460 countsByYear W22633634602023 @default.
• W2263363460 crossrefType "journal-article" @default.
• W2263363460 hasAuthorship W2263363460A5031335804 @default.
• W2263363460 hasAuthorship W2263363460A5047366894 @default.
• W2263363460 hasAuthorship W2263363460A5063078246 @default.
• W2263363460 hasAuthorship W2263363460A5071814877 @default.
• W2263363460 hasAuthorship W2263363460A5091358989 @default.
• W2263363460 hasBestOaLocation W22633634601 @default.
• W2263363460 hasConcept C121608353 @default.
• W2263363460 hasConcept C126322002 @default.
• W2263363460 hasConcept C142724271 @default.
• W2263363460 hasConcept C143998085 @default.
• W2263363460 hasConcept C204232928 @default.
• W2263363460 hasConcept C204787440 @default.
• W2263363460 hasConcept C2776336362 @default.
• W2263363460 hasConcept C2777596629 @default.
• W2263363460 hasConcept C2779013556 @default.
• W2263363460 hasConcept C2780140570 @default.
• W2263363460 hasConcept C2780849966 @default.
• W2263363460 hasConcept C2992571226 @default.
• W2263363460 hasConcept C2993294228 @default.
• W2263363460 hasConcept C3020774429 @default.
• W2263363460 hasConcept C526584372 @default.
• W2263363460 hasConcept C71924100 @default.
• W2263363460 hasConcept C95190672 @default.
• W2263363460 hasConceptScore W2263363460C121608353 @default.
• W2263363460 hasConceptScore W2263363460C126322002 @default.
• W2263363460 hasConceptScore W2263363460C142724271 @default.
• W2263363460 hasConceptScore W2263363460C143998085 @default.
• W2263363460 hasConceptScore W2263363460C204232928 @default.
• W2263363460 hasConceptScore W2263363460C204787440 @default.
• W2263363460 hasConceptScore W2263363460C2776336362 @default.
• W2263363460 hasConceptScore W2263363460C2777596629 @default.
• W2263363460 hasConceptScore W2263363460C2779013556 @default.
• W2263363460 hasConceptScore W2263363460C2780140570 @default.
• W2263363460 hasConceptScore W2263363460C2780849966 @default.
• W2263363460 hasConceptScore W2263363460C2992571226 @default.
• W2263363460 hasConceptScore W2263363460C2993294228 @default.
• W2263363460 hasConceptScore W2263363460C3020774429 @default.
• W2263363460 hasConceptScore W2263363460C526584372 @default.
• W2263363460 hasConceptScore W2263363460C71924100 @default.
• W2263363460 hasConceptScore W2263363460C95190672 @default.
• W2263363460 hasLocation W22633634601 @default.
• W2263363460 hasLocation W22633634602 @default.
• W2263363460 hasLocation W22633634603 @default.
• W2263363460 hasLocation W22633634604 @default.
• W2263363460 hasOpenAccess W2263363460 @default.
• W2263363460 hasPrimaryLocation W22633634601 @default.
• W2263363460 hasRelatedWork W102369865 @default.
• W2263363460 hasRelatedWork W2263363460 @default.
• W2263363460 hasRelatedWork W2319308768 @default.
• W2263363460 hasRelatedWork W2352755873 @default.

• next